Zimmer Biomet shares at $105 reveal value at 13 times adjusted earnings, as the company continues to grow despite a GLP-1 ...

Medical device company Zimmer Biomet (NYSE:ZBH) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 4.3% year ...

4. Zimmer Biomet has entered into a definitive agreement to purchase Paragon 28, a medical device company focused exclusively on foot-and-ankle orthopedics.

Total revenue of $6.3M Includes $3.3 Million of Product Revenue in Addition to a One-Time Upfront Payment of $3.0 Million in License Revenue from ...

Surgery Partners. In 2024, Surgery Partners added five new ASCs and two orthopedic ASCs in Chicago through a partnership with Duly Health. It also added over 230 physicians across orthopedics, spine ...

BD announced it would split from its biosciences and diagnostics unit, while Zimmer Biomet updated investors on its $1.1 ...

NeuroOne Medical Technologies Corporation ( NASDAQ: NMTC) Q1 2025 Earnings Conference Call February 12, 2025 8:30 AM ET ...

The global joint replacement devices market, valued at US$22.50 billion in 2023, is forecasted to grow at a robust CAGR of 4.8%, reaching US$23.42 ...

In a report released today, Caitlin Cronin from Canaccord Genuity maintained a Hold rating on Zimmer Biomet Holdings (ZBH – Research Report), ...

The firm spun out its dental and spine businesses ... With an ROA of 1.15%, the company may face hurdles in achieving optimal financial returns. Debt Management: Zimmer Biomet Holdings's debt ...

The firm spun out its dental and spine businesses in 2022. A Deep Dive into Zimmer Biomet Holdings's Financials Market Capitalization Analysis: Positioned below industry benchmarks, the company's ...